U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. CDER Small Business & Industry Assistance (SBIA)
  5. CDER SBIA Chronicles
  1. CDER Small Business & Industry Assistance (SBIA)

CDER Small Business & Industry Assistance (SBIA) Chronicles

FDA/CDER SBIA Chronicles, newsletter of the CDER Small Business and Industry Assistance team, provides industry with useful information to assist in all aspects of drug marketing and regulation. If you have topics of interest, please email us at CDERSBIA@fda.hhs.gov.


Listen on Apple Podcasts

Listen on YouTube Podcasts

Listen on Spotify Podcasts

TitleDatePodcast
Improving Data Quality with Centralized Statistical Monitoring - with Dr. Paul Schuette and Xiaofeng (Tina) WangDecember 13, 2024

 Podcast

(12:30 min, 17.2MB, MP3)
Transcript

The Need for Artificial Intelligence in Pharmacovigilance with Dr. Robert BallNovember 14, 2024

 Podcast

(11:00 min, 15.1MB, MP3)
Transcript

Considerations for Drug Products that Contain NanomaterialsMay 17, 2024

 Podcast

(11:19 min, 16.2MB, MP3)
Transcript

Using Bayesian Statistical Approaches to Advance our Ability to Evaluate Drug ProductsAugust 17, 2023

 Podcast

(7:30 min, 10.3MB, MP3)
Transcript

Insights About the FDA/EMA Parallel Scientific Advice Program for Complex Generic/Hybrid Drug ProductsJuly 10, 2023

 Podcast

(7:58 min, 7.31MB, MP3)
Transcript

The Role of Pharmacodynamic Biomarkers in Biosimilar Drug DevelopmentApril 10, 2023

 Podcast

(9:48 min, 13.5MB, MP3)
Transcript

FDA Regulation and Quality Considerations for Cannabis and Cannabis-Derived CompoundsFebruary 6, 2023

 Podcast

(11:28 min, 10.5MB, MP3)
Transcript

The FDA Compounding Incidents Program: Adverse Events Associated with Compounded Drugs from Outsourcing FacilitiesSeptember 29, 2022

 Podcast

(7:09 min, 6.54MB, MP3)
Transcript

An FDA Self-Audit of Continuous Manufacturing for Drug ProductsJune 28, 2022

 Podcast

(11:12 min, 10MB, MP3)
Transcript

The Key Elements of Being “Recall-Ready”April 19, 2022

 Podcast

(7:51 min, 7.4MB, MP3)
Transcript

The ABCs of Product Specific GuidancesSeptember 2, 2021

 Podcast

(7:23 min, 6.8MB, MP3)
Transcript

Improving Regulatory Communication via the CDER NextGen PortalDecember 19, 2019

 Podcast

(6:01 min, 6.8MB, MP3)
Transcript

Abbreviated Approval Pathways for Drug Product: 505(b)(2) or ANDA?September 19, 2019

 Podcast

(7:48 min, 9.6MB, MP3)
Transcript

Research Investigational New Drug Applications – What You Need to KnowJune 25, 2019

 Podcast

(4:58 min, 6.8MB, MP3)
Transcript

Competitive Generic TherapiesMay 23, 2019

 Podcast

(6:49 min, 9.49MB, MP3)
Transcript

FDA Modernizes Clinical Trials with Master ProtocolsFebruary 26, 2019

 Podcast

(5:34 min, 5.1MB, MP3)
Transcript


 

SUBSCRIBE

Get regular FDA email updates delivered on this topic to your inbox.

Back to Top